NaV1.9: a sodium channel linked to human pain
- PMID: 26243570
- DOI: 10.1038/nrn3977
NaV1.9: a sodium channel linked to human pain
Abstract
The voltage-gated sodium channel Na(V)1.9 is preferentially expressed in nociceptors and has been shown in rodent models to have a major role in inflammatory and neuropathic pain. These studies suggest that by selectively targeting Na(V)1.9, it might be possible to ameliorate pain without inducing adverse CNS side effects such as sedation, confusion and addictive potential. Three recent studies in humans--two genetic and functional studies in rare genetic disorders, and a third study showing a role for Na(V)1.9 in painful peripheral neuropathy--have demonstrated that Na(V)1.9 plays an important part both in regulating sensory neuron excitability and in pain signalling. With this human validation, attention is turning to this channel as a potential therapeutic target for pain.
Similar articles
-
Voltage-gated sodium channels: therapeutic targets for pain.Pain Med. 2009 Oct;10(7):1260-9. doi: 10.1111/j.1526-4637.2009.00719.x. Pain Med. 2009. PMID: 19818036 Review.
-
The role of voltage-gated sodium channels in neuropathic pain.Curr Opin Neurobiol. 2003 Jun;13(3):291-7. doi: 10.1016/s0959-4388(03)00074-6. Curr Opin Neurobiol. 2003. PMID: 12850213 Review.
-
Voltage-gated sodium channels and pain pathways.J Neurobiol. 2004 Oct;61(1):55-71. doi: 10.1002/neu.20094. J Neurobiol. 2004. PMID: 15362153 Review.
-
No gain, no pain: NaV1.7 as an analgesic target.ACS Chem Neurosci. 2014 Sep 17;5(9):749-51. doi: 10.1021/cn500171p. Epub 2014 Aug 11. ACS Chem Neurosci. 2014. PMID: 25111714 Review.
-
Voltage-gated sodium channels in pain states: role in pathophysiology and targets for treatment.Brain Res Rev. 2009 Apr;60(1):65-83. doi: 10.1016/j.brainresrev.2008.12.005. Epub 2008 Dec 25. Brain Res Rev. 2009. PMID: 19150627 Review.
Cited by
-
A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain.Eur J Pharmacol. 2016 Aug 5;784:1-14. doi: 10.1016/j.ejphar.2016.05.006. Epub 2016 May 5. Eur J Pharmacol. 2016. PMID: 27158117 Free PMC article.
-
The μ-opioid receptor differentiates two distinct human nociceptive populations relevant to clinical pain.Cell Rep Med. 2024 Oct 15;5(10):101788. doi: 10.1016/j.xcrm.2024.101788. Cell Rep Med. 2024. PMID: 39413733 Free PMC article.
-
From Perception Threshold to Ion Channels-A Computational Study.Biophys J. 2019 Jul 23;117(2):281-295. doi: 10.1016/j.bpj.2019.04.041. Epub 2019 Jun 14. Biophys J. 2019. PMID: 31255293 Free PMC article.
-
Voltage-gated sodium channels: (NaV )igating the field to determine their contribution to visceral nociception.J Physiol. 2018 Mar 1;596(5):785-807. doi: 10.1113/JP273461. Epub 2018 Feb 6. J Physiol. 2018. PMID: 29318638 Free PMC article. Review.
-
Pain insensitivity: distal S6-segment mutations in NaV1.9 emerge as critical hotspot.Neurogenetics. 2017 Jul;18(3):179-181. doi: 10.1007/s10048-017-0513-9. Epub 2017 Mar 13. Neurogenetics. 2017. PMID: 28289907 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical